[Synthesis of potential CCK antagonist quinazolone derivatives]. 1995

M Szabó, and J Kökösi, and L Orfi
Semmelweis Orvostudományi Egyetem, Gyógyszerészi Kémiai Intézet, Budapest.

An original route has been found for the synthesis of [1,4]diazepino-quinazolones, a new ring system of heterocondensed quinazolones. These anthranilicacid-alanin-beta-alanin cyclopeptide derivatives constitute a structural moiety of asperlicin, the first natural cholecystokinin antagonist alkaloid. These compounds are therefore potential CCK antagonists. The new compounds were prepared via condensation of 2-amino-alkyl-quinazolones, obtained from 2-alkyl-quinazolones by side-chain substitution, with 1,3-bifunctional-reagents. We studied the cyclisation process under basic, acidic and phase-transfer catalyzed conditions. The structures of the synthesized compounds were characterized by IR, UV and NMR spectroscopy.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D002766 Cholecystokinin A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety. Pancreozymin,CCK-33,Cholecystokinin 33,Uropancreozymin
D013053 Spectrophotometry The art or process of comparing photometrically the relative intensities of the light in different parts of the spectrum.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

M Szabó, and J Kökösi, and L Orfi
July 2011, Medicinal chemistry (Shariqah (United Arab Emirates)),
M Szabó, and J Kökösi, and L Orfi
May 1996, Farmaco (Societa chimica italiana : 1989),
M Szabó, and J Kökösi, and L Orfi
July 1984, Journal of pharmaceutical sciences,
M Szabó, and J Kökösi, and L Orfi
November 1977, Indian journal of experimental biology,
M Szabó, and J Kökösi, and L Orfi
September 2007, European journal of medicinal chemistry,
M Szabó, and J Kökösi, and L Orfi
February 2006, European journal of medicinal chemistry,
M Szabó, and J Kökösi, and L Orfi
April 1995, Acta crystallographica. Section C, Crystal structure communications,
M Szabó, and J Kökösi, and L Orfi
January 1965, Acta physiologica Academiae Scientiarum Hungaricae,
M Szabó, and J Kökösi, and L Orfi
October 1957, Scientia Sinica,
M Szabó, and J Kökösi, and L Orfi
April 1975, Die Pharmazie,
Copied contents to your clipboard!